Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

{% set status = marketHours.currentMarketStatus if marketHours.currentMarketStatus == "pre-market" or marketHours.currentMarketStatus == "after-hours" %}{% set hasHighAndLow = tickerData.data[dynamicVariables.equity upper].high and tickerData.data[dynamicVariables.equity upper].low %}{% if resolvedDynamicVariables[dynamicVariables.equity].subclass == "stock" %} () 股票 今日價格為 ，自市場 {% if status %} 上次收盤 {% else %} 開盤以來錄得 變動。該公司的市值為 ，日交易量為 股。{% if hasHighAndLow %}對於關注價格走勢的投資者而言， 股票今日的波動區間介於 和 之間。{% endif %} 上一個收盤價為 。{% else %} () ETF 今日價格為 。  ETF 當前 {% if resolvedDynamicVariables[dynamicVariables.equity].market_cap %} 市值為 ，{% endif %} 日交易量為 股。

{% if hasHighAndLow %}對於分析 ETF 表現的投資者而言， 當天的波動區間在 和 之間，前一交易日收盤價為 。透過這些資料可以深入了解近期的價格波動和流動性。{% endif %}

{% endif %}

是否準備好開始交易？請按照以下步驟操作，或閱讀我們的指南 如何在 Kraken 上購買 Ultragenyx Pharmaceutical 股票，起始金額為 $10。